⚠️ Not investment advice. This is a quantitative research tool; every decision is the user's own responsibility. Past performance does not guarantee future results.⚠️ Not investment advice. Past performance does not guarantee future results.
⚠️ Not investment advice. Past performance does not guarantee future results.
🔓 Sign up freeSee the full rankingSign in with Google
← Back to the full ranking · All companies

Equifax EFX

United States Industrials
5.2/10
AI Analyst score
148.11 USD
Last price at analysis date · analyst target 214.38 (+44.7%)
🛒 Where to buy EFXPartner brokers · US (NYSE/Nasdaq) · sample 200.00 € orderUS (NYSE/Nasdaq)
Meridian is paid by these brokers at no extra cost to you; this is not investment advice. Public fee schedules · commission and FX, taxes excluded · Compare all 22 brokers by real cost →
No partner-broker fees for this market yet · Broker cost comparison →
🟡 HOLD — Hold, but with caution: valuation is reasonable and the business has a moat, but earnings growth is weak and the high-rate environment pressures the balance sheet.

Equifax is a credit reporting agency that collects and analyzes consumer and business financial data to sell credit reports, scores, and risk analytics services to lenders and other organizations. Equifax shows moderate financial health (ND/EBITDA 2.75) and acceptable business quality (ROIC 11.33%), but earnings growth is almost nil (0.70%) and the stock has fallen 42% from highs, trading at 52-week lows. Forward valuation (P/E 14.58) suggests the market has already priced in part of the risk, but the high-rate environment and the student debt litigation add uncertainty.

Financial health
4.7
Quality / Moat
6.2
Valuation
5.8
Growth
5.6
Dividend
6.2
Momentum
1.2
Risk & Context
4.3

Detailed metrics

Market and fundamental data as of the analysis date.

💵 Valuation
P/E26.03
Fwd P/E14.58
EV/EBITDA11.87
P/B3.98
P/S2.70
PEG1.24
Market cap17.40 B USD
Enterprise value22.84 B USD
🏰 Quality and moat
ROIC (approx.)11.3%
Gross margin55.54%
FCF conversion49%
Operating margin17.30%
📈 Profitability and margins
ROE14.27%
ROA6.16%
Net margin10.73%
FCF947.5 M USD
FCF yield5.45%
🏦 Solvency and liquidity
Total debt5.47 B USD
Net debt5.30 B USD
Cash170.1 M USD
EBITDA1.92 B USD
Net debt / EBITDA2.75
D/E120.96
Current ratio0.60
Quick ratio0.51
🚀 Growth
Revenue growth10.60%
Earnings growth0.70%
EPS (TTM)5.69 USD
EPS (Fwd)10.16 USD
💰 Dividend and risk
Dividend yield1.51%
Payout37.3%
Beta1.30
Analyst consensusBuy (21)
Target price214.38 USD
52-week range146.80 USD – 258.40 USD
⚠️ Main risk: The main risk is the combination of a leveraged balance sheet (ND/EBITDA 2.75, liquidity 0.60) with a rising-rate environment, which makes refinancing more expensive and could further compress already near-zero earnings growth.
See the full analysis and compare with the rest of the ranking →

Full AI report

Generated automatically from the metrics, the macro context and the company's news.

Equifax is a credit reporting agency that collects and analyzes consumer and business financial data to sell credit reports, scores, and risk analytics services to lenders and other organizations. Equifax shows moderate financial health (ND/EBITDA 2.75) and acceptable business quality (ROIC 11.33%), but earnings growth is almost nil (0.70%) and the stock has fallen 42% from highs, trading at 52-week lows. Forward valuation (P/E 14.58) suggests the market has already priced in part of the risk, but the high-rate environment and the student debt litigation add uncertainty.

Score by category

CategoryScore
Financial health4.7
Quality / Moat6.2
Valuation5.8
Growth5.6
Dividend6.2
Momentum1.2
Risk & Context4.3

OVERALL SCORE: 5.2/10

Context and risks

Equifax operates in a highly regulated sector (credit reporting) and faces active litigation, including lawsuits over student debt cancellation on credit reports. Additionally, its business is sensitive to the credit cycle: with 10-year Treasury yields at 5.17% and a tightening credit environment, demand for credit reports could weaken.

News considered in the analysis

  • Student Loan Debt Was Supposed to Be Gone — Borrowers Sue Trump Administration Over Canceled Debt on Credit Reports — Litigio sobre la cancelación de deuda estudiantil en informes de crédito; si prospera, podría afectar la precisión de los datos de Equifax y generar costes legales, aunque el impacto directo en beneficios es incierto.
  • Equifax (EFX) Stock Still Looks Undervalued Despite Its 41% Slide — Artículo de análisis que sugiere que la acción está infravalorada tras la caída; es una opinión de analista, pero refleja un posible punto de entrada tras el desplome.
  • Equifax (EFX) Hits a 52-Week Low. The Shares Are Down 42% From Their High — Confirmación de que la acción está en mínimos de 52 semanas; el movimiento ya está en el precio y no aporta información nueva sobre fundamentales.
  • Can OneTru Help TransUnion Sustain Its Growth Momentum? — Noticia sobre un competidor (TransUnion); no tiene impacto directo en Equifax.
  • Here's Why Investors Should Hold EFX Stock in Their Portfolios Now — Recomendación de mantener la acción; es una opinión de analista sin información nueva material.

Verdict: Hold, but with caution: valuation is reasonable and the business has a moat, but earnings growth is weak and the high-rate environment pressures the balance sheet.

Main risk: The main risk is the combination of a leveraged balance sheet (ND/EBITDA 2.75, liquidity 0.60) with a rising-rate environment, which makes refinancing more expensive and could further compress already near-zero earnings growth.

Other Industrials companies

Neighbours in the sector ranking, to compare without going back to the index.

See all 1,000+ companies in the index →

Automatically generated analysis from fundamental, market and news data. Not personalised financial advice — a research tool, not an individual recommendation. Past performance does not guarantee future results. Last update of this analysis: 2026-09-28. Legal notice, privacy & cookies.